Circulating tumour cells for early detection of clinically relevant cancer

Nature Reviews Clinical Oncology, Published online: 02 June 2023; doi:10.1038/s41571-023-00781-yThe authors of this Perspective propose that, with further improvement in detection efficiency, circulating tumour cells (CTCs), which are released early during cancer development, have the potential to be used for the early detection of clinically relevant, aggressive cancers. Thus, use of CTCs as diagnostic biomarkers might improve outcomes by enabling the identification of cancers at a stage at which they are more amenable to treatment while avoiding overtreatment of patients with indolent tumours.
Source: Nature Reviews Clinical Oncology - Category: Cancer & Oncology Authors: Source Type: research